Shimin Chen

Shimin Chen

Auto-generated profile, based on publicly available information

Shimin Chen

Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
JLJichun Lin
Jichun Lin
WFWenshuo Fang
Wenshuo Fang
ZXZhuo Xiang
Zhuo Xiang
QWQingqing Wang
Qingqing Wang
HCHuapeng Cheng
Huapeng Cheng
LMLeina Ma
Leina Ma
Immune therapies targeting the PD-1/PD-L1 pathway have been employed in the treatment of breast cancer, which requires aerobic glycolysis to sustain breast cancer cells growth. However, whether PD-L1 expression is regulated by glycolysis in breast cancer cells remains to be further elucidated. Here, we demonstrate that glycolytic enzyme hexokinase 2 (HK2) plays a crucial role in upregulating PD-L1 expression. Under high glucose conditions, HK2 acts as a protein kinase and phosphorylates IκBα at T291 in breast cancer cells, leading to the rapid degradation of IκBα and activation of NF-κB, which enters the nucleus and promotes PD-L1 expression. Immunohistochemistry staining of human breast cancer specimens and bioinformatics analyses reveals a positive correlation between HK2 and PD-L1 expression levels, which are inversely correlated with immune cell infiltration and survival time of breast cancer patients. These findings uncover the intrinsic and instrumental connection between aerobic glycolysis and PD-L1 expression-mediated tumor cell immune evasion and underscore the potential to target the protein kinase activity of HK2 for breast cancer treatment.

9 June 2020 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
EZE. Zhao
E. Zhao
CZC. Zhou
C. Zhou
SCS. Chen
S. Chen

1 January 2021 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
EZEnfa Zhao
Enfa Zhao
CZChangli Zhou
Changli Zhou
SCShimin Chen
Shimin Chen

18 January 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
EZEnfa Zhao
Enfa Zhao
SCShimin Chen
Shimin Chen
YDYajuan Du
Yajuan Du
YZYushun Zhang
Yushun Zhang
Numerous reports have been done to seek the relationship between sleep apnea hypopnea syndrome (SAHS) and the risk of atrial fibrillation (AF). However, definite conclusion has not yet been fully established. We examined whether SAHS increases AF incidence in common population and summarized all existing studies in a meta-analysis. We summarized the current studies by searching related database for potential papers of the association between SAHS and the risk of AF. Studies that reported original data or relative risks (RRs) with 95% confidence intervals (CIs) for the associations were included. Sensitivity analyses were performed by omitting each study iteratively and publication bias was detected by Begg’s tests. Eight eligible studies met the inclusion criteria. Fixed effects meta-analysis showed that SAHS increased AF risk in the common population (RR = 1.70, 95% CI: 1.53–1.89, P=0.002, I2=69.2%). There was a significant association between mild SAHS and the risk of AF (RR = 1.52, 95% CI: 1.28–1.79, P=0.01, I2=78.4%), moderate SAHS (RR = 1.88, 95% CI: 1.55–2.27, P=0.017, I2=75.6%), and severe SAHS (RR = 2.16, 95% CI: 1.78–2.62, P<0.001, I2=91.0%). The results suggest that sleep apnea hypopnea syndrome could increase the risk of AF, and the higher the severity of SAHS, the higher risk of atrial fibrillation.

1 September 2021 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
SCShimin Chen
Shimin Chen
EZEnfa Zhao
Enfa Zhao

2 December 2019 in Future Oncology
Verified
Journal Article
Closed access
EZEnfa Zhao
Enfa Zhao
CZChangli Zhou
Changli Zhou
SCShimin Chen
Shimin Chen
Aim: To build a prognostic nomogram based on log odds of positive lymph nodes for patients with gastric carcinoma (GC) after resection, and to compare the predictive performance with the American J...